首页> 外文期刊>Experimental and therapeutic medicine >Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus
【24h】

Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus

机译:胱抑素C在2型糖尿病患者肾损害中的作用及最佳的肾损害临界值

获取原文
获取原文并翻译 | 示例
       

摘要

The aims of the present study were to evaluate the roles of serum cystatin C (SCysC) and urinary cystatin C (UCysC) in renal function impairment and investigate the optimum cut-off point for renal function impairment among patients with type 2 diabetes mellitus (DM). A total of 742 inpatients and outpatients with type 2 DM (age, 20-75 years) were enrolled in this population-based cross-sectional study. The levels of SCysC and UCysC were determined and the odds ratios (ORs) and 95% confidence interval (CIs) of the calculated risk ratios of the different renal damage indicators were obtained. The levels of UCysC, urinary β2-microglobulin (Uβ2-MG), urinary albumin (UALB) and SCysC in the renal function impairment groups were observed in the following order: GFR-C>GFR-B>GFR-A (P<0.05 or P<0.01). According to the levels of GFR were divided into 4 groups, group GFR-A ≥ 80ml/min, GFR-B group 50-80 ml/min, group Ccr-C 20-50 ml/min, group GFR-D <20 ml/min. Following adjustment for age and gender, multivariate correlation analysis results revealed that levels of Uβ2-MG, UCysC and UALB negatively correlated with the glomerular filtration rate (GFR; P<0.05 or P<0.01). In addition, the duration of DM and the levels of SCysC and serum uric acid were shown to positively correlate with the GFR (P<0.05 or P<0.01). ORs for early renal function impairment significantly increased from the DM duration category of four years (OR, 1.74; 95% CI, 1.54-1.92). Receiver operating characteristic analysis demonstrated that the optimum DM cut-off point was four years, in which 60.79% sensitivity and 69.66% specificity were observed. Therefore, UCsyC levels may be used as an efficient indicator for the evaluation of early renal function impairment among patients with type 2 DM. In addition, renal lesions may initially occur in the renal tubule and then form in the renal glomerulus of patients with type 2 DM.
机译:本研究的目的是评估血清半胱氨酸蛋白酶抑制剂C(SCysC)和尿半胱氨酸蛋白酶抑制剂C(UCysC)在肾功能损害中的作用,并探讨2型糖尿病(DM)患者肾功能损害的最佳临界点)。这项基于人群的横断面研究共纳入742名2型DM住院和门诊患者(年龄20-75岁)。确定SCysC和UCysC的水平,并获得不同肾脏损害指标的计算风险比的比值比(OR)和95%置信区间(CIs)。肾功能损害组的UCysC,尿β2-微球蛋白(Uβ2-MG),尿白蛋白(UALB)和SCysC水平按以下顺序观察:GFR-C> GFR-B> GFR-A(P <0.05或P <0.01)。根据GFR水平分为4组,GFR-A组≥80ml/ min,GFR-B组50-80ml / min,Ccr-C组20-50ml / min,GFR-D <20ml /分钟。在调整了年龄和性别之后,多元相关分析结果显示,Uβ2-MG,UCysC和UALB的水平与肾小球滤过率呈负相关(GFR; P <0.05或P <0.01)。此外,DM持续时间以及SCysC和血清尿酸水平与GFR呈正相关(P <0.05或P <0.01)。早期肾功能损害的OR从四年的DM持续时间类别显着增加(OR,1.74; 95%CI,1.54-1.92)。接收器工作特性分析表明,最佳DM截止点为四年,其中观察到60.79%的敏感性和69.66%的特异性。因此,UCsyC水平可以用作评估2型DM患者早期肾功能损害的有效指标。此外,肾损伤可能最初发生在肾小管中,然后在2型DM患者的肾小球中形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号